Pharmaceuticals - Indian - Formulations
Peer Comparison
Company | LTP | Market Cap (in ₹ Cr) |
---|---|---|
Bafna Pharmaceuticals Ltd | ₹80.13 | ₹189.56 |
Sun Pharmaceuticals Industries Ltd | ₹1,858.70 | ₹4,45,964.39 |
Divis Laboratories Ltd | ₹5,901 | ₹1,56,653.01 |
Cipla Ltd | ₹1,559.20 | ₹1,25,920.28 |
Torrent Pharmaceuticals Ltd | ₹3,207.70 | ₹1,08,558.27 |
Mankind Pharma Ltd | ₹2,690.55 | ₹1,07,795.31 |
05 Sep 2024
04 Sep 2024
10 Aug 2024
28 May 2024
03 Feb 2024
Financials
Profit and Loss
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Total Revenue | 155.99 | 118.62 | 86.84 | 71.97 | 42.73 |
Total Expenses | 148.64 | 107.01 | 79.47 | 66.14 | 44.61 |
Profit Before Tax | 7.35 | 11.62 | 5.22 | 5.83 | -1.88 |
Profit After Tax | 7.35 | 11.34 | 5.22 | 5.83 | -1.88 |
Operating Profit after Depreciation | 9.64 | 13.65 | 8.17 | 6.57 | -1.78 |
Balance Sheet
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Fixed Assets | 41.98 | 41.73 | 38.85 | 35.97 | 34.97 |
Total Non Current Assets | 53.21 | 42.27 | 39.26 | 36.80 | 35.18 |
Total Current Assets | 94.47 | 87.31 | 50.88 | 49.67 | 35.88 |
TOTAL ASSETS | 147.68 | 129.58 | 90.14 | 86.47 | 71.06 |
Total Shareholder's Fund | 80.84 | 73.45 | 61.96 | 56.77 | 50.95 |
Cash Flow
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Net Cash from Operating Activities | 9.48 | 4.95 | 9.73 | -13.61 | -34.27 |
Net Cash used in Investing Activities | -15.05 | -7.49 | -6.54 | -5.35 | 32.78 |
Net Cash used in Financing Activities | -0.85 | 10.18 | -4.81 | 12.28 | 7.27 |
Corporate Actions